Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

811
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

901
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
901
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

163
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
163

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In vitro</i> dormancy models improve ability to predict treatment response in severe marmoset tuberculosis lesions.

bioRxiv : the preprint server for biology·2026
Same author

Impacts of heminode disruption on auditory processing of noisy sound stimuli.

bioRxiv : the preprint server for biology·2026
Same author

Distinct mechanisms drive post-antibiotic Tuberculosis relapse post-cure versus post-treatment-failure.

bioRxiv : the preprint server for biology·2026
Same author

GEODE: an <i>in silico</i> tool that translates <i>in vitro</i> to <i>in vivo</i> predictions of tuberculosis antibiotic combination efficacy.

Frontiers in pharmacology·2025
Same author

Religious and culturally conscious sleep care for Muslim patients: Clinical considerations and recommendations.

Sleep medicine reviews·2025
Same author

Rankings of tuberculosis antibiotic treatment regimens are sensitive to spatial scale, detection limit, and initial host bacterial burden.

Journal of theoretical biology·2025

Related Experiment Video

Updated: Jan 10, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K

A novel machine-learning based optimization: identifying new treatment regimens for tuberculosis.

Maral Budak1, Pariksheet Nanda1, Denise Kirschner1

  • 1Dept. of Microbiology and Immunology, University of Michigan Medical School 48109-5620, Ann Arbor, MI, United States.

Numerical Algebra, Control and Optimization
|November 24, 2025
PubMed
Summary

This study introduces a novel machine learning pipeline for system optimization, applicable to complex models like agent-based systems beyond traditional differential equations. The method optimizes drug treatment regimens for tuberculosis, providing ranked outcomes for improved patient care.

Keywords:
Agent-based modelDrug treatmentMachine learningMathematical biologyOptimizationRankingTuberculosis

More Related Videos

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Jan 10, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

2.2K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.3K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Computational Biology and Bioinformatics
  • Machine Learning and Artificial Intelligence
  • Systems Biology and Pharmacology

Background:

  • Traditional optimal control theory is limited to ordinary differential equation (ODE) systems.
  • Complex systems, such as agent-based models (ABMs), require more versatile optimization approaches.
  • Balancing multiple objectives and trade-offs is crucial for effective system optimization.

Purpose of the Study:

  • To develop a novel machine learning optimization pipeline for diverse system models.
  • To apply the pipeline to optimize drug treatment regimens for Mycobacterium tuberculosis infection.
  • To provide ranked, optimized treatment outcomes for complex therapeutic decisions.

Main Methods:

  • Developed a machine learning optimization pipeline utilizing a Kriging-based surrogate model.
  • Employed a Pareto optimization algorithm to identify and rank optimal objective function improvements.
  • Applied the pipeline to a Mycobacterium tuberculosis host-pathogen interaction model.

Main Results:

  • Successfully optimized complex treatment regimens for tuberculosis, considering drug combinations and dosages.
  • Generated a ranked set of optimized treatment outcomes, linking directly to model predictions.
  • Demonstrated the pipeline's applicability to agent-based models beyond traditional ODE systems.

Conclusions:

  • The novel machine learning pipeline offers a flexible and powerful approach to system optimization.
  • This method enables data-driven optimization of complex therapeutic strategies, exemplified by tuberculosis treatment.
  • The approach provides valuable, ranked insights for decision-making in personalized medicine and drug development.